Funded Grants and Contracts

John M. Brooks, co-investigator (Robert Wallace, PI, $99,997) NIH,  “Lung Cancer Care Outcomes/Surveillance Consortium Iowa.”

Elizabeth Chrischilles, PI, has received funding from Merck Company Foundation in the amount of $40,000, “Merck Predoctoral Fellowship in Epidemiology at The University of Iowa.”

Elizabeth Chrischilles, N. Hohatsu, D. Anton, M. Aquilino, L. Burmeister, T. Cook, F. Gerr, J. Lowe, J. Schneider, L. Snetselaar, F. Wolinsky, co-investigators (James Merchant, PI, $1,000,000) US Department of Health & Human Services, “Healthier Workforce Center for Excellence.”

Elizabeth Chrischilles, R. Wallace, H. An, C. Pavlik, J. Geweke, G. Rosenthal, co-investigators (F. Wolinsky, PI, $355,619) NIH, “Health and Health Services Use in the HRS/AHEAD.”

Elizabeth Chrischilles, D. Lubaroff, co-investigators (Robert Wallace, PI, $610,600) NIH, “Integrating Aging and Cancer Research.”

Barry L. Carter, PI, [co-investigators Elizabeth Chrischilles, William R. Doucette, A. Hartz, J. Dawson, J. Milchak, G. Bergus, P. James] has received funding from NIH in the amount of $615,123, “Improving Adherence to Blood Pressure Guidelines.”

Jonathan A. Doorn, PI, has received funding from NIH in the amount of $100,158, “Protein Modification by 3,4-Dihydroxyphenylacetaldehyde.”

William Doucette, PI, [co-investigators Karen Farris and Randy McDonough] has received funding from the Community Pharmacy Foundation in the amount of $59,838.

Michael W. Duffel, G. Buettner, T. Cook, P. Goswami, M. Jones, H. Lehmler, G. Ludewig, D. Osterberg, D. Spitz, P. Thorne, B. Van Aken, K. Hornbuckle, J. Schnoor, co-investigators (Larry Robertson, PI, $2,998,990) NIH, “Semi-Volatile PCBs: Sources, Exposures, Toxicities.”

Michael W. Duffel, PI, has received funding from NIH in the amount of $227,666, “Aryl and Alcohol Sulfotransferases in Drug Metabolism.”

Larry Fleckenstein, PI, has received funding from World Health Organization in the amount of $62,407, “Moxidectin HPLC Analysis in Plasma and Pharmacokinetic Evaluation.”

Larry Fleckenstein, PI, has received funding from Medicines for Malaria Venture in the amount of $382,214, “Analysis of Pyronaridine and Artesunate for Pyronaridine-Artesunate Development Project.”

Robert Kerns, PI, has received funding from NIH in the amount of $184,375, “Saccharide-Based Effects of Cationic Antimicrobial Peptides.”

Thomas Prisinzano, PI, has received funding from NIH in the amount of $322,856, “Investigation of Neoclerodanes as Novel Opioid Ligands.” 

Thomas Prisinzano, PI, has received funding from NIH in the amount of $37,377, “Investigation of Neoclerodanes as Novel Opioid Ligands.”  (Supplement)

Aliasger K. Salem, co-investigator (Sarah Larsen, PI, $129,663) NSF, “NER: Self-Assembly of Nanostructures in Functionalized, Hierarchial Zeolite Structures.”

Aliasger K. Salem, PI, has received funding from Parenteral Drug Association.

Peter Veng-Pedersen, R. Strauss, L. Richmond, S. Lindgren, E. Bell, D. Bonthius, R. Hohl, L. Burmeister, M. Zimmerman, P. Nopoulos, A. Rijhsinghani, V. Magnotta, co-investigators (John Widness, PI, $1,910,068) NIH, “Neonatal Anemia: Pathophysiology and Treatment.”